DE3521733C2 - - Google Patents

Info

Publication number
DE3521733C2
DE3521733C2 DE19853521733 DE3521733A DE3521733C2 DE 3521733 C2 DE3521733 C2 DE 3521733C2 DE 19853521733 DE19853521733 DE 19853521733 DE 3521733 A DE3521733 A DE 3521733A DE 3521733 C2 DE3521733 C2 DE 3521733C2
Authority
DE
Germany
Prior art keywords
ifn
gamma
preparation
alpha
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE19853521733
Other languages
German (de)
English (en)
Other versions
DE3521733A1 (de
Inventor
Josef Dr Brzoska
Johann-Friedrich Von Eichborn
Hans-Joachim Dr Obert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Bioferon Biochemische Substanzen GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL76591A priority Critical patent/IL76591A0/xx
Application filed by Bioferon Biochemische Substanzen GmbH and Co filed Critical Bioferon Biochemische Substanzen GmbH and Co
Priority to DE19853521733 priority patent/DE3521733A1/de
Priority to EP85111184A priority patent/EP0181455B2/de
Priority to DE8585111184T priority patent/DE3583849D1/de
Priority to AT85111184T priority patent/ATE66375T1/de
Priority to JP60218143A priority patent/JP2662214B2/ja
Priority to DK198504524A priority patent/DK174585B1/da
Priority to EP85112625A priority patent/EP0177910A3/de
Priority to IL76591A priority patent/IL76591A/xx
Priority to CA000492377A priority patent/CA1288694C/en
Priority to AU48412/85A priority patent/AU588547C/en
Publication of DE3521733A1 publication Critical patent/DE3521733A1/de
Priority to US07/510,714 priority patent/US5145677A/en
Application granted granted Critical
Publication of DE3521733C2 publication Critical patent/DE3521733C2/de
Priority to JP9061337A priority patent/JP3048533B2/ja
Priority to JP10339113A priority patent/JPH11255665A/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19853521733 1984-10-05 1985-06-18 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von tumoren und viruserkrankungen in niedriger dosierung Granted DE3521733A1 (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IL76591A IL76591A0 (en) 1984-10-05 1984-10-06 Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
DE19853521733 DE3521733A1 (de) 1985-06-18 1985-06-18 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von tumoren und viruserkrankungen in niedriger dosierung
EP85111184A EP0181455B2 (de) 1984-10-05 1985-09-04 Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur systemischen Behandlung von verschiedenen Erkrankungen des Menschen in niedriger Dosierung
DE8585111184T DE3583849D1 (de) 1984-10-05 1985-09-04 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
AT85111184T ATE66375T1 (de) 1984-10-05 1985-09-04 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
JP60218143A JP2662214B2 (ja) 1984-10-05 1985-10-02 低投与量にてヒトの筋萎縮性側索硬化症を系統的に治療するためのγ―インターフェロン含有組成物
DK198504524A DK174585B1 (da) 1984-10-05 1985-10-04 Anvendelse af gamma-inteferon til fremstilling af farmaceutiske præparater til systemisk behandling af forskellige sygdomme hos mennesker i lave doser
EP85112625A EP0177910A3 (de) 1984-10-05 1985-10-04 Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur systemischen Behandlung von verschiedenen Erkrankungen des Menschen in niedriger Dosierung
IL76591A IL76591A (en) 1984-10-05 1985-10-06 Pharmaceutical compositions containing ifn-ypsilon for the treatment or prevention of malignant or viral diseases
CA000492377A CA1288694C (en) 1984-10-05 1985-10-07 Process for treatment of diseases
AU48412/85A AU588547C (en) 1984-10-05 1985-10-07 Process for treatment of diseases
US07/510,714 US5145677A (en) 1984-10-05 1990-04-18 Process for treatment of diseases
JP9061337A JP3048533B2 (ja) 1984-10-05 1997-03-14 低投与量にてアレルギー疾患を系統的に治療するための組換えヒトγ−インタフェロン含有組成物
JP10339113A JPH11255665A (ja) 1984-10-05 1998-11-30 低投与量にて腫瘍性または新生組織性細胞増殖を系統的に治療するための組換えヒトγ―インタフェロン含有組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853521733 DE3521733A1 (de) 1985-06-18 1985-06-18 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von tumoren und viruserkrankungen in niedriger dosierung

Publications (2)

Publication Number Publication Date
DE3521733A1 DE3521733A1 (de) 1986-12-18
DE3521733C2 true DE3521733C2 (cs) 1991-04-11

Family

ID=6273515

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853521733 Granted DE3521733A1 (de) 1984-10-05 1985-06-18 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von tumoren und viruserkrankungen in niedriger dosierung

Country Status (1)

Country Link
DE (1) DE3521733A1 (cs)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
US4507281A (en) * 1981-10-13 1985-03-26 Exovir, Inc. Interferon-containing compositions
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
US4483849A (en) * 1983-01-07 1984-11-20 Carter William A Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product

Also Published As

Publication number Publication date
DE3521733A1 (de) 1986-12-18

Similar Documents

Publication Publication Date Title
EP0181455B2 (de) Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur systemischen Behandlung von verschiedenen Erkrankungen des Menschen in niedriger Dosierung
DE3789239T2 (de) Pharmazeutische Zusammensetzung enthaltend Interferon für bukkale Verabreichung.
DE69433921T2 (de) Rekombinante zellen der monozyten-makrophagen zelllinie zur gen-therapie
DE69333321T3 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
DE69020573T2 (de) Verfahren zur wachstumshemmung von stammzellen.
DE3423234A1 (de) Synergistische mischungen von interferonen und tumor-nekrose-faktor
DE69001484T2 (de) Verwendung von menschlichen BCDF für die Herstellung einer Zusammensetzung für die Behandlung von Thrombocytopenia.
DE69628838T2 (de) Chemokin bindendes protein und verfahren zu seiner verwendung
DE69007744T2 (de) Verwendung von Interleukin 2 zur Behandlung von Leukämien.
DE3308030A1 (de) Tierische interferone
EP0231819A2 (en) Pharmaceutical agent for the treatment of myelogenous leukemia
DE4422859C2 (de) Wäßrige Zellextrakte aus Mykobacterien
EP0180737B1 (de) Verwendung von Interferon gamma (IFN-gamma) zur Herstellung von Präparationen zur Behandlung rheumatischer Erkrankungen
DE69832902T2 (de) Oromukosal-zytokin-zusammensetzungen und ihre verwendung
DE3521733C2 (cs)
Crockett et al. Side effects and toxicity of interferon in the treatment of recurrent respiratory papillomatosis
Werner-Wasik et al. Endogeneous interferon α/β produced by murine Kupffer cells augments liver-associated natural killing activity
HUGHES et al. Do the interferons act singly or in combination?
DE69224786T2 (de) Die Verwendung von Interleukin-6 zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Lymphocytic Leukemia und B-Zell Lymphoma.
DE69332904T2 (de) Hemmung von hiv-infektion
DE3608608A1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von autoimmunerkrankungen, viruserkrankungen und malignen erkrankungen des menschen in niedriger dosierung
EP0205629A1 (de) Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen
DE69230501T2 (de) Antiviraler faktor aus cd8+ zellen
DE3436637A1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung von schmerzen
EP0889053B1 (de) BK-RiV-Präparate zur Behandlung von proliferativen Zellerkrangungen

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3546568

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3546568

D2 Grant after examination
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: DR. RENTSCHLER BIOTECHNOLOGIE GMBH, 88471 LAUPHEIM

8327 Change in the person/name/address of the patent owner

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, 55218 ING